Fig. 5
From: Renal function in β-thalassemia major patients treated with two different iron-chelation regimes
Correlation between urinary Ca/Cr ratio and Hb levels in All patients group (r = 0.41, p = 0.001), in patients treated with DFX (r = 0.32, p = 0.1) and in patients treated with DFO+/−DFP (r = 0.7, p = 0.018). (DFX) Deferasirox. (DFO) Desferrioxamine. (DFP) Deferiprone